Academy in Ghana aims to develop world leaders
Founded with the help of MIT Sloan classmates, an MIT Executive MBA graduate’s new school will teach entrepreneurship and innovation.
Founded with the help of MIT Sloan classmates, an MIT Executive MBA graduate’s new school will teach entrepreneurship and innovation.
Peter Howard SM ’84 is the CEO of Realtime Robotics, a startup transforming autonomous robot motion planning to enable seamless, affordable human-robot collaboration.
2021 Global Change Outlook from the MIT Joint Program on the Science and Policy of Global Change shows how more aggressive policies can sharply reduce climate risk.
Ranked at the top for the 10th straight year, the Institute also places first in 12 subject areas.
Ten principal investigators from seven MIT departments and labs will receive up to $150,000 for two years, overhead-free, for innovative research on global food and water challenges.
MIT instructors honored for creating multidimensional, multidisciplinary online courses that help learners everywhere address real-world problems.
How a pair of MIT Sloan Executive Education alumni translated teachings from an MIT course to operations improvements at Mexico’s largest brewery.
Yichen Shen PhD '16 is CEO of Lightelligence, an MIT spinout using photonics to reinvent computing for artificial intelligence.
Nearly 1,400 joined the AI for Health Care Equity Conference that explored new AI technologies as a platform for change.
Six new IDEAS teams receive grants to continue developing their work with communities.
Osmoses says its filtration membranes can make gas and vapor separation much less energy-intensive across multiple industries.
Grants will support their research, graduate study, and teaching abroad in 2021-22.
In the U.S. and globally, cultures with a high level of collectivism tend to encourage masking during the pandemic.
Yes, in some ways. A new study shows Twitter users post even more misinformation after other users correct them.
A machine learning model developed jointly by Janssen and MIT data scientists played a key role in the clinical trial process for the Johnson & Johnson Covid-19 vaccine.